论文部分内容阅读
本文报告40例神经外科病人试用Ⅱ号氟碳代血 液的临床研究。研究结果表明输注过程中生命体征平稳,PaO_2明显升高,具有扩容和抗休克的效应。对缺血性脑血管病输注后,神经体征明显改善。本组病例未出现过敏反应,除2例一过性转氨酶升高,血小板及免疫功能一过性下降外,其他肝肾功能及生化参数等均保持在正常范围内。经研究表明Ⅱ号氟碳代血液能代替或减少部分库血的输注,用于失血性休克的救治和缺血性脑血管病的治疗是有效的。
This article reports the clinical study of 40 patients with neurosurgery trial of fluorocarbon Ⅱ blood. The results show that during the infusion of vital signs stable, PaO_2 significantly increased, with expansion and anti-shock effect. After the infusion of ischemic cerebrovascular disease, neurological signs improved significantly. No allergic reaction in this group of patients, in addition to two cases of transient transaminase increased, transiently decreased platelet and immune function, other liver and kidney function and biochemical parameters were maintained within the normal range. The research shows that the fluorocarbon Ⅱ blood can replace or reduce the infusion of some of the blood for the treatment of hemorrhagic shock and ischemic cerebrovascular disease is effective.